Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moxon

Showing results (61-70 of 304) with videos related to

Pageof 31
Sort By:
Science (New York, N.Y.)|June 8, 2000
Microbiology. When being hyper keeps you fitB P Rainey, E R Moxon
Vaccine|April 1, 1988
Type b capsular polysaccharide as a virulence factor of Haemophilus influenzaeE R Moxon, J S Kroll
Infection and Immunity|September 1, 1989
Identification and characterization of a serotype b-specific segment of the Haemophilus influenzae genomeS Ely, J Tippett, E R Moxon
Lancet (London, England)|November 15, 1986
Fatal neonatal varicella infectionP Holland, D Isaacs, E R Moxon
Advances in Experimental Medicine and Biology|March 14, 1998
Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infectionsE R Moxon, D Hood, J Richards
Archives of Disease in Childhood|December 1, 1985
Prevention of spread of echovirus 6 in a special care baby unitD Isaacs, A Wilkinson, E R Moxon
Molecular Microbiology|October 1, 1994
Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactionsM Virji, K Makepeace, E R Moxon
Microbial Pathogenesis|February 1, 1994
Interactions of Neisseria meningitidis with human monocytesG McNeil, M Virji, E R Moxon
Vaccine|February 13, 1999
For discussion: live attenuated vaccines for group B meningococcusC Tang, R Moxon, M M Levine
Microbial Pathogenesis|February 1, 1995
Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and piliK L Dunn, M Virji, E R Moxon
Pageof 31

Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
Science (New York, N.Y.)|June 8, 2000
Microbiology. When being hyper keeps you fitB P Rainey, E R Moxon
Vaccine|April 1, 1988
Type b capsular polysaccharide as a virulence factor of Haemophilus influenzaeE R Moxon, J S Kroll
Infection and Immunity|September 1, 1989
Identification and characterization of a serotype b-specific segment of the Haemophilus influenzae genomeS Ely, J Tippett, E R Moxon
Lancet (London, England)|November 15, 1986
Fatal neonatal varicella infectionP Holland, D Isaacs, E R Moxon
Advances in Experimental Medicine and Biology|March 14, 1998
Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infectionsE R Moxon, D Hood, J Richards
Archives of Disease in Childhood|December 1, 1985
Prevention of spread of echovirus 6 in a special care baby unitD Isaacs, A Wilkinson, E R Moxon
Molecular Microbiology|October 1, 1994
Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactionsM Virji, K Makepeace, E R Moxon
Microbial Pathogenesis|February 1, 1994
Interactions of Neisseria meningitidis with human monocytesG McNeil, M Virji, E R Moxon
Vaccine|February 13, 1999
For discussion: live attenuated vaccines for group B meningococcusC Tang, R Moxon, M M Levine
Microbial Pathogenesis|February 1, 1995
Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and piliK L Dunn, M Virji, E R Moxon
Pageof 31